Data as of Nov 26
| -0.41 / -4.18%|
The 4 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 21.25, with a high estimate of 33.00 and a low estimate of 7.00. The median estimate represents a +126.06% increase from the last price of 9.40.
The current consensus among 5 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.